Aurinia Pharmaceuticals Inc. chief legal officer Stephen P. Robertson trims stake with $189,516 sale
An open-market sale on Nov 13, reported to the SEC on Nov 16, not marked as part of a 10b5-1 plan. Information only, not investment advice.
A chief legal officer at Aurinia Pharmaceuticals Inc., Stephen P. Robertson, sold 11,867 shares of the company's stock on the open market on Nov 13. The sale, at an average of $15.97 a share, comes to $189,516.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The filing came 3 days after the trade.
It is the third insider sale at Aurinia Pharmaceuticals Inc. reported in the last 90 days. After the trade, the filing lists 576,981 shares held.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Aurinia Pharmaceuticals Inc. (AUPH) |
|---|---|
| Insider | Stephen P. Robertson |
| Role | Chief Legal Officer |
| Transaction | Open-market sale (code S) |
| Shares | 11,867 |
| Average price | $15.97 |
| Value | $189,516 |
| Trade date | Nov 13, 2026 |
| Filed with the SEC | Nov 16, 2026, 4:25 PM ET |
| Shares held after | 576,981 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.